Analyst Reco. Vaxcyte, Inc.

Equities

PCVX

US92243G1085

Market Closed - Nasdaq Other stock markets 16:00:00 2024-05-02 EDT			5-day change	1st Jan Change
64.55 ^USD	+1.32%		+7.48%	+2.79%

04-25	Vaxcyte Insider Sold Shares Worth $928,845, According to a Recent SEC Filing	MT
04-22	Vaxcyte Insider Sold Shares Worth $490,199, According to a Recent SEC Filing	MT

Analyst Reco.

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Vaxcyte Insider Sold Shares Worth $928,845, According to a Recent SEC Filing	04-25	MT
Vaxcyte Insider Sold Shares Worth $552,144, According to a Recent SEC Filing	03-21	MT
Mizuho Adjusts Price Target on Vaxcyte to $113 From $69, Maintains Buy Rating	03-12	MT
Needham Raises Price Target on Vaxcyte to $95 From $73, Maintains Buy Rating	02-28	MT
Mizuho Initiates Vaxcyte With Buy Rating, Price Target is $69	12-07	MT
TD Cowen Starts Vaxcyte at Outperform	23-04-18	MT
BofA Securities Adjusts Price Target on Vaxcyte to $68 From $63, Keeps Buy Rating	23-04-18	MT
Guggenheim Adjusts Price Target on Vaxcyte to $65 From $66, Maintains Buy Rating	23-02-28	MT
Needham Adjusts Price Target on Vaxcyte to $58 From $52, Maintains Buy Rating	23-01-03	MT
SVB Securities Initiates Vaxcyte With Outperform Rating, Sets Price Target at $60	22-12-16	MT
Guggenheim Initiates Vaxcyte at Buy With $66 Price Target	22-12-15	MT
BTIG Starts Vaxcyte at Buy With $69 Price Target	22-11-17	MT

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Secure and Increase the Performance of your Investments with our Team of Experts at your Side

Securing my Investments

fermer